Efficacy of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) in women

Asian Journal of Surgery

Volumn 30, Issue 2, 2007, Pages 131-137

  Pummangura, Nithi ^a   Kochakarn, Wachira ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Lower urinary tract symptoms; Tamsulosin; Urinary flow rate

Indexed keywords

EID: 34249660042     PISSN: 10159584     EISSN: 02193108     Source Type: Journal    
DOI: 10.1016/S1015-9584(09)60146-9     Document Type: Article

References (20)

1. Hunskaar S, Arnold EP, Burgio K, et al. Epidemiology and natural history of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:301-19.
2. Lapitan MC, Chye PL. The epidemiology of overactive bladder among females in Asia: a questionnaire survey. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:226-31.
3. Moller LA, Lose G, Jorgensen T. The prevalence and bothersomeness of lower urinary tract symptoms in women 40-60 years of age. Acta Obstet Gynecol Scand 2000;79:298-305.
4. Swithinbank LV, Donovan JL, du Heaume JC, et al. Urinary symptoms and incontinence in women: relationships between occurrence, age, and perceived impact. Br J Gen Pratct 1999;49:897-900.
5. Schwinn DA, Michelotti GA. Alpha1-adrenergic receptors in the lower urinary tract and vascular bed: potential role for the alpha1d subtype in filling symptoms and effects of ageing on vascular expression. BJU Int 2000;2(Suppl 85):6-11.
6. Abrams P, Schulman CC, Vaage S. Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group. Br J Ural 1995;76:325-36.
7. Buzelin JM, Fonteyne E, Kontturi M, et al. Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group. Br J Urol 1997;80:597-605.
8. Chapple CR, Wyndaele JJ, Nordling J, et al. Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A metaanalysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. Eur Urol 1996;29:155-67.
9. Lee E, Lee C. Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses. Br J Urol 1997;80:606-11.
10. Lepor H. Phase in multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group. J Urol 1998;1:892-900.
11. Narayan P, Tewari A. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. United States 93-01 Study Group. J Urol 1998;160:1701-6.
12. Chai TC, Belville WD, McGuire EJ, Nyquist L Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes. J Urol 1993;150:1710-3.
13. Chancellor MB, Rivas DA. American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia. J Urol 1993;150:1706-9.
14. Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. J Urol 1993;42:36-41.
15. Scarpero HM, Fiské J, Xue X, Nitti VW. American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. J Urology 2003;61:1118-22.
16. Lepor H, Theune C. Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatismlike symptoms. J Urol 1995;154:116-8.
17. Serels S, Stein M. Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women. Neurourol Urodyn 1998;17:31-6.
18. Malloy BJ, Price DT, Price RR, et al. Alpha1-adrenergic receptor subtypes in human detrusor. J Urol 1998;160:937-43.
19. Smith MS, Schambra UB, Wilson KH, et al. Alpha1-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alphal-adrenergic receptor subtypes at four distinct levels. Brain Res Mol Brain Res 1999;63:254-61.
20. Chapple CR. Pharmacotherapy for benign prostatic hyperplasia- the potential for alpha 1-adrenoceptor subtype-specific blockade. Br J Urol 1998;(81 Suppl 1):34-47; discussion 64-6.